ARTICLE | Company News
AGY Therapeutics, M's Science deal
July 26, 2004 7:00 AM UTC
M's granted AGY exclusive rights to develop and commercialize AGY-94806 (or SA4503), a small molecule sigma receptor agonist, for certain indications. M's has completed a Phase I trial of the compound...